Roth Capital Resums Coverage on Antares Pharma (AIS) at Buy
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Price: $68.16 +1.25%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Roth Capital resumes coverage on Antares Pharma (NYSE: AIS) with a Buy. PT $3.50.
For more ratings news on Antares Pharma click here and for the rating history of Antares Pharma click here.
Shares of Antares Pharma closed at $1.58 yesterday.
For more ratings news on Antares Pharma click here and for the rating history of Antares Pharma click here.
Shares of Antares Pharma closed at $1.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
- Citi initiates Meitu Inc coverage with Buy rating, HK$7 target
- CICC Starts Hilton Worldwide (HLT) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
